Wall Street Strategies
Login:  
Password:
  remember me
Sign Up | Lost Password
Question of the Week

Great news from the National Federation of Independent Businesses (NFIB) as the optimism reading leaped to the highest level since 2004.

Are you feeling more optimistic? And, if you are a business owner looking to hire, is it difficult to find qualified candidates?

Click here to post your answer and let Charles know what you think.

Catch Charles on Wednesday morning with Bill Handle at 8:20am Pacific. Charles invites his KFI listeners to take a free trial! Click here to sign up!

 Jan 18 - Click here to listen to the show!



Wall Street Strategies, Inc. is an independent stock market research company.

Our daily goal is to help our subscribers make money in the stock market. Our unbiased approach is coupled with personalized service that guides investors throughout the entire life cycle of each trade. Learn more

Portfolio Review
Get our opinion on any stock in your portfolio. Find out why Charles Payne is the most popular independent analyst on Wall Street.
>> GET A PORTFOLIO REVIEW ON THE STOCK OF YOUR CHOICE


Philosophy
We believe investors should take an approach to the stock market based first and foremost on understanding the stocks in their portfolios beyond the chart formation. The key to long term success isn't picking winning stocks but knowing which stock picks to hold onto during adverse conditions. Learn more.

Methodology
Our approach to investment advice focuses on a balanced allocation of funds, industry exposure, and realistic expectations. 70% of your stock portfolio should be in core positions while 30% should try to generate cash actively. Learn more.


Charles Payne's Market Commentary
This Is Just The Calm...
1/19/2017 - “Modest increases” was the buzz phrase for employment, wages,
and construction in the Federal Reserve’s Beige Book report.
Prices climbed in eight of the 12 Fed districts underscoring a
spike that sent the Consumer Price Index (CPI) report to a two-
year high.... MORE

Get FREE Stock Market Commentary! | Take a free trial
Recent commentary from Charles
Lots of Data
1/18/2017 1:55:23 PM By Charles Payne, CEO & Principal Analyst
Trump Takes Victory Lap - Too Much Too Soon?
1/18/2017 9:32:13 AM By Charles Payne, CEO & Principal Analyst
Odd Free Trade Bedfellows
1/17/2017 12:42:36 PM By Charles Payne, CEO & Principal Analyst
Positive Gyrations From Dow 20,000 Stall
1/17/2017 9:19:23 AM By Charles Payne, CEO & Principal Analyst
Hope and Change (Free Market Style)
1/13/2017 9:02:14 AM By Charles Payne, CEO & Principal Analyst



Roadmap For Investing Success
The market is soaring and if you want a piece of the action, you should take the plunge without taking too much of a risk.  Well, you’re not alone. However, I must say that the idea of making a lot of money with no risk is typically called a confidence trick or a Ponzi scheme. These days, it’s Read more.

Wall Street Strategies' Latest Articles
Economy
Big Business Gets Hip To Trump
1/18/2017 By Charles Payne, CEO & Principal Analyst
I applaud the way President-elect Donald Trump has employed Twitter and social media to create a new omnipotent bully-pulpit. I am beginning to wonder if big business is getting hip by playing the public relations game instead of making serious business adjustments. Read more.
Economy
Leveling the Playing Field
1/13/2017 By Charles Payne, CEO & Principal Analyst
Donald Trump ran on a platform of fewer government regulations and leveling the global playing field for American businesses. Comments from Delta set up a great and long overdue showdown – we will see Read more.
Economy
Trump's Extraordinary Press Conference
1/12/2017 By Charles Payne, CEO & Principal Analyst
It was an extraordinary news conference that made for an extraordinary session for the stock market. Naturally, his comments on spending and the need for new bidding procedures spooked drug and biotechnology stocks. Read more.
Economy
Drug Companies Under Fire
1/12/2017 By Charles Payne, CEO & Principal Analyst
I have been to drug manufacturing facilities, and it’s mostly mashing powder into pills. It’s not rocket science, so it is surprising how much of the U.S. drug company production is done outside the U Read more.

Older Headlines

MAIN STREET WISDOM
Observations of a concerned public

Kathy Murphy tweets:
Listen to @cvpayne ...time to shop the market!
...more

Voice your comments, ideas or frustrations!

Trump Rally Report
In this free 10 page special report, Investing and President Trump, Charles looks at what the winning sectors and trades will be in the Trump Rally. The 2016 election post-mortem has created a narrative that everyone is shocked at Donald Trump's win, including "the markets". I don't agree. Read more

Subscribe Now




Free Registration
Get Charles Payne's daily Market Commentary emails. Take a free 1 week trial subscription and get a portfolio review.
First Name:
Last Name:
Email:
Phone:
Password:
 

Charles Payne's Common Sense Newsletter

Home | Products & Services | Education | In The Media | Help | About Us |
Disclaimer | Updated Privacy Policy | Terms of Use |
All Rights Reserved.